A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries

ConclusionsMost analysed countries show a trend towards value-based approaches that consider value for money to society, but also other economic, clinical, and humanistic criteria. Good practices included robustness, transparency, independence, and participation.
Source: Applied Health Economics and Health Policy - Category: Health Management Source Type: research